title: Severe anaphylactic shock after rechallenge with abacavir without preceding hypersensitivity.
authors.forename: P H
authors.initials: PH
authors.lastname: Frissen
authors.forename: J
authors.initials: J
authors.lastname: de Vries
authors.forename: H M
authors.initials: HM
authors.lastname: Weigel
authors.forename: K
authors.initials: K
authors.lastname: Brinkman
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D000328:Adult; D000707:Anaphylaxis / Q000139:chemically induced* / Q000503:physiopathology; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015224:Dideoxynucleosides / Q000009:adverse effects* / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000209:etiology*; D006801:Humans; D008297:Male; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D000099227:Abacavir
chemical_list: D019380:Anti-HIV Agents; D015224:Dideoxynucleosides; D018894:Reverse Transcriptase Inhibitors; D000099227:Abacavir